IU Simon Comprehensive Cancer Center shared a post on LinkedIn:
“A new discovery from IU Simon Comprehensive Cancer Center and Indiana University School of Medicine researchers could lead to more effective therapies for acute myeloid leukemia (AML), one of the most aggressive and fatal blood cancers in adults.
The team identified a previously unknown immune cell linked to AML progression. Because current treatments often lead to relapse or resistance, this finding could help create better-targeted therapies—and improve outcomes for patients.
AML starts in the bone marrow and interferes with blood cell formation. It’s currently the sixth-leading cause of cancer-related death in adults.”
More posts featuring Acute Myeloid Leukemia on OncoDaily.